Literature DB >> 9091643

Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene.

K Xie1, S Huang, Z Dong, S H Juang, Y Wang, I J Fidler.   

Abstract

BACKGROUND: The activation of an enzyme, inducible nitric oxide synthase (iNOS), catalyzes the production of endogenous nitric oxide (NO). NO, in turn, is associated with cell death, suppression of tumor development, and inhibition of metastasis of murine melanoma cells. Moreover, the in vivo induction of iNOS is associated with regression of established hepatic metastases. Whether this regression required the activation of the iNOS gene in every tumor cell or whether NO-producing tumor cells can also kill bystander (neighboring) cells has been previously unknown.
PURPOSE: The goal of this study was to determine whether cells producing NO and then undergoing autolysis can also kill bystander cells in vitro and in vivo.
METHODS: Murine K-1735 C4.parental (C4.P) melanoma cells were transfected with the functional iNOS gene (transfectant denoted as C4.L8) or with a control truncated-nonfunctional iNOS gene (transfectant denoted as C4.S2). NO-mediated cytolysis and bystander cell killing were determined in vitro and in vivo.
RESULTS: Only the functional iNOS-transfected C4.L8 cells produced NO and underwent autolysis. C4.L8 cells also produced statistically significant lysis of iNOS-negative C4.P cells. This lysis was suppressed by the specific iNOS inhibitor N(G)-methyl-L-arginine. NO-producing C4.L8 cells and control C4.P or C4.S2 cells were injected subcutaneously into syngeneic C3H/HeN mice. Control C4.P and C4.S2 cells produced rapidly growing subcutaneous tumors, whereas C4.L8 cells did not. The mixture of C4.P and C4.S2 cells (1:5 ratio) produced rapidly growing subcutaneous tumors, whereas the mixture of C4.P and C4.L8.5 cells (1:5 ratio) produced slow-growing tumors. The subcutaneous growth of C4.P cells was not affected by C4.L8.5 cells injected subcutaneously at a distant site. Mixtures of C4.P cells labeled with [(125)I]iododeoxyuridine and C4.L8 cells (NO producing) or C4.S2 cells (control) were injected subcutaneously. The survival rate of the radiolabeled cells indicated that the NO-producing C4.L8.5 cells lysed the bystander C4.P cells.
CONCLUSION: The production of high-level endogenous NO causes autolysis in tumor cells and lysis of bystander cells under in vitro and in vivo conditions. IMPLICATIONS: NO-mediated cell killing does not require transfection of genes into every cell in a neoplasm.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9091643     DOI: 10.1093/jnci/89.6.421

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

Review 1.  Nitric oxide and angiogenesis.

Authors:  M Ziche; L Morbidelli
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

2.  Evidence for control of nitric oxide synthesis by intracellular transforming growth factor-beta1 in tumor cells. Implications for tumor development.

Authors:  P Lagadec; S Raynal; B Lieubeau; N Onier; L Arnould; V Saint-Giorgio; D A Lawrence; J F Jeannin
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

3.  Nitric oxide synthase 2 gene polymorphisms are associated with prostatic volume in Korean men with benign prostatic hyperplasia.

Authors:  Koo Han Yoo; Su Kang Kim; Joo-Ho Chung; Sung-Goo Chang
Journal:  Asian J Androl       Date:  2010-06-21       Impact factor: 3.285

Review 4.  Liposome-mediated gene therapy in the kidney.

Authors:  Keiichi Ito; Jie Chen; Tomohiko Asano; E Darracott Vaughan; Dix P Poppas; Masamichi Hayakawa; Diane Felsen
Journal:  Hum Cell       Date:  2004-03       Impact factor: 4.174

Review 5.  Regulation of cancer metastasis by stress pathways.

Authors:  Keping Xie; Suyun Huang
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

6.  Synergic induction of human periodontal ligament fibroblast cell death by nitric oxide and N-methyl-D-aspartic acid receptor antagonist.

Authors:  Taegun Seo; Seho Cha; Kyung Mi Woo; Yun-Soo Park; Yun-Mi Cho; Jeong-Soon Lee; Tae-Il Kim
Journal:  J Periodontal Implant Sci       Date:  2011-02-28       Impact factor: 2.614

7.  Mulberry extracts alleviate aβ 25-35-induced injury and change the gene expression profile in PC12 cells.

Authors:  Nan Song; Hongpeng Yang; Wei Pang; Zhiwei Qie; Hao Lu; Long Tan; Haiqiang Li; Shoudan Sun; Fuzhi Lian; Chuan Qin; Yugang Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-17       Impact factor: 2.629

8.  Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment.

Authors:  Cian M McCrudden; John W McBride; Joanne McCaffrey; Ahlam A Ali; Nicholas J Dunne; Vicky L Kett; Jonathan A Coulter; Tracy Robson; Helen O McCarthy
Journal:  Mol Ther Nucleic Acids       Date:  2016-12-31       Impact factor: 8.886

Review 9.  Nitric Oxide-Mediated Enhancement and Reversal of Resistance of Anticancer Therapies.

Authors:  Emily Hays; Benjamin Bonavida
Journal:  Antioxidants (Basel)       Date:  2019-09-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.